286 related articles for article (PubMed ID: 20154262)
21. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
22. Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor beta(1).
Tzanidis A; Lim S; Hannan RD; See F; Ugoni AM; Krum H
J Mol Cell Cardiol; 2001 May; 33(5):969-81. PubMed ID: 11343419
[TBL] [Abstract][Full Text] [Related]
23. Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.
Uchinaka A; Kawaguchi N; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N
Cardiovasc Res; 2013 Jul; 99(1):102-10. PubMed ID: 23615564
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction.
Boyle AJ; Kelly DJ; Zhang Y; Cox AJ; Gow RM; Way K; Itescu S; Krum H; Gilbert RE
J Mol Cell Cardiol; 2005 Aug; 39(2):213-21. PubMed ID: 15878171
[TBL] [Abstract][Full Text] [Related]
25. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.
Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Tsutsui H; Kaibuchi K; Takeshita A
Circulation; 2004 May; 109(18):2234-9. PubMed ID: 15096457
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction.
Grimm D; Cameron D; Griese DP; Riegger GA; Kromer EP
Cardiovasc Res; 1998 Nov; 40(2):297-306. PubMed ID: 9893723
[TBL] [Abstract][Full Text] [Related]
27. Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating β-Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting β-Catenin.
Eid RA; Khalil MA; Alkhateeb MA; Eleawa SM; Zaki MSA; El-Kott AF; Al-Shraim M; El-Sayed F; Eldeen MA; Bin-Meferij MM; Awaji KME; Shatoor AS
Cardiovasc Drugs Ther; 2021 Dec; 35(6):1095-1110. PubMed ID: 32474680
[TBL] [Abstract][Full Text] [Related]
28. Cardiac remodeling by fibrous tissue after infarction in rats.
Sun Y; Zhang JQ; Zhang J; Lamparter S
J Lab Clin Med; 2000 Apr; 135(4):316-23. PubMed ID: 10779047
[TBL] [Abstract][Full Text] [Related]
29. Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion.
Rajani SF; Imani A; Faghihi M; Izad M; Kardar GA; Salehi Z
Eur J Pharmacol; 2019 Mar; 847():61-71. PubMed ID: 30684466
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of histone deacetylase on ventricular remodeling in infarcted rats.
Lee TM; Lin MS; Chang NC
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H968-77. PubMed ID: 17400721
[TBL] [Abstract][Full Text] [Related]
31. Exogenous high-mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF-β/Smad signaling pathway.
He Y; Zhou X; Zheng X; Jiang X
J Cell Biochem; 2013 Jul; 114(7):1634-41. PubMed ID: 23355476
[TBL] [Abstract][Full Text] [Related]
32. Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway.
Gu Y; Wang X; Wang X; Yuan M; Wu G; Hu J; Tang Y; Huang C
Tohoku J Exp Med; 2012 Jul; 227(3):161-70. PubMed ID: 22729178
[TBL] [Abstract][Full Text] [Related]
33. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
Yung LM; Nikolic I; Paskin-Flerlage SD; Pearsall RS; Kumar R; Yu PB
Am J Respir Crit Care Med; 2016 Nov; 194(9):1140-1151. PubMed ID: 27115515
[TBL] [Abstract][Full Text] [Related]
34. α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways.
Alrasheed NM; Alammari RB; Alshammari TK; Alamin MA; Alharbi AO; Alonazi AS; Bin Dayel AF; Alrasheed NM
BMC Cardiovasc Disord; 2023 Mar; 23(1):153. PubMed ID: 36964489
[TBL] [Abstract][Full Text] [Related]
35. Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.
Chen YH; Wang Q; Li CY; Hou JW; Chen XM; Zhou Q; Chen J; Wang YP; Li YG
J Mol Cell Cardiol; 2017 Apr; 105():1-11. PubMed ID: 28214509
[TBL] [Abstract][Full Text] [Related]
36. Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction.
Liu CF; Liu QH; Liu EL; Zhai XW; Zhang L; Luo TE; Zhang WF; Feng QL; Cui XL; Zhao ZQ; Cao JM; Wu BW
J Cardiovasc Pharmacol; 2014 Oct; 64(4):345-56. PubMed ID: 25286360
[TBL] [Abstract][Full Text] [Related]
37. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
[TBL] [Abstract][Full Text] [Related]
38. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
Zhang YL; Zhou SX; Wang MH; Wang JF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
[TBL] [Abstract][Full Text] [Related]
39. Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway.
Liu A; Gao X; Zhang Q; Cui L
Mol Med Rep; 2013 Aug; 8(2):361-6. PubMed ID: 23732925
[TBL] [Abstract][Full Text] [Related]
40. Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels.
Huang W; Rubinstein J; Prieto AR; Wang DH
J Hypertens; 2010 Feb; 28(2):367-76. PubMed ID: 19887954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
